Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease

Journal of Virology

Volumn 72, Issue 1, 1998, Pages 121-132

  Hanna, Zaher ^a,b   Kay, Denis G ^a   Cool, Marc ^a   Jothy, Serge ^c   Rebai, Najet ^a   Jolicoeur, Paul ^a,b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; DISEASE SEVERITY; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; TRANSGENIC MOUSE; VIRUS EXPRESSION; VIRUS GENOME;

EID: 0031964791     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.1.121-132.1998     Document Type: Article

References (59)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Bettelheim, F. A., F. F. Zeng, Y. Bia, S. J. Tumminia, and P. Russell. 1995. Lens hydration in transgenic mice containing HIV-1 protease linked to the lens alpha A-crystallin promoter. Arch. Biochem. Biophys. 324:223-227.
3. Bodi, I., A. Abraham, and P. L. Kimmel. 1994. Macrophages in human immunodeficiency virus-associated kidney diseases. Am. J. Kidney Dis. 24: 762-767.
4. Brady, H. J., D. J. Pennington, C. G. Miles, and E. A. Dzierzak. 1993. CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J. 12:4923-4932.
5. Calvelli, T. A., and A. Rubinstein. 1990. Pediatric HIV infection: a review. Immunodefic. Rev. 2:83-127.
6. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
7. Clarke, J. R., D. S. Robinson, R. J. Coker, R. F. Miller, and D. M. Mitchell. 1995. Role of the human immunodeficiency virus within the lung. Thorax 50:567-576.
8. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
9. Coodley, G. O., M. O. Loveless, and T. M. Merrill. 1994. The HIV wasting syndrome: a review. J. Acquired Immune Defic. Syndr. 7:681-694.
10. Crowe, S. M., and R. S. Kornbluth. 1994. Overview of HIV interactions with macrophages and dendritic cells: the other infection in AIDS. J. Leukocyte Biol. 56:215-217.
11. De Rossi, A., M. L. Calabro, M. Panozzo, D. Bernardi, B. Caruso, G. Tridente, and L. Chieco-Bianchi. 1990. In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res. Hum. Retroviruses 6:287-298.
12. Dickie, P. 1996. HIV type 1 Nef perturbs eye lens development in transgenic mice. AIDS Res. Hum. Retroviruses 12:177-189.
13. Dickie, P., J. Felser, M. Eckhaus, J. Bryant, J. Silver, N. Marinos, and A. L. Notkins. 1991. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185:109-119.
14. Dickie, P., R. Gazzinelli, and L. J. Chang. 1996. Models of HIV type 1 proviral gene expression in wild-type HIV and MLV/HIV transgenic mice. AIDS Res. Hum. Retroviruses 12:1103-1116.
15. Dickie, P., F. Ramsdell, A. L. Notkins, and S. Venkatesan. 1993. Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. Virology 197:431-408.
16. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359-362.
17. Enger, C., N. Graham, Y. Peng, J. S. Chmiel, L. A. Kingsley, R. Detels, and A. Munoz. 1996. Survival from early, intermediate, and late stages of HIV infection. JAMA 275:1329-1334.
18. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529-534.
19. Garcia, J. V., and A. D. Miller. 1991. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350:508-511.
20. Gaulton, G. N., J. V. Scobie, and M. Rosenzweig. 1997. HIV-1 and the thymus. AIDS 11:403-414.
21. Goudreau, G., S. Carpenter, N. Beaulieu, and P. Jolicoeur. 1996. Vacuolar myelopathy in transgenic mice expressing human immunodcfiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter. Nat. Med. 2:655-661.
22. Grunfeld, C., and K. R. Feingold. 1992. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N. Engl. J. Med. 327:329-337.
23. + T cells and in macrophages of transgenic mice. Mol. Cell. Biol. 14:1084-1094.
24. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
25. Ho, D. D. 1996. Viral counts count in HIV infection. Science 272:1124-1125.
26. Humphreys, M. H. 1995. Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int. 48:311-320.
27. Iwakura, Y., T. Shioda, M. Tosu, E. Yoshida, M. Hayashi, T. Nagata, and Shibuta H. 1992. The induction of cataracts by HIV-1 in transgenic mice. AIDS 6:1069-1075.
28. Jolicoeur, P., A. Laperrière, and N. Beaulieu. 1992. Efficient production of human immunodeficiency virus proteins in transgenic mice. J. Virol. 66:3904-3908.
29. Joshi, V. 1994. Pathology of acquired immunodeficiency syndrome in children. Pediatr. Hematol. Oncol. 11:351-355.
30. Karlsson-Parra, A., E. Dimeny, B. Fellstrom, and L. Klareskog. 1989. HIV receptors (CD4 antigen) in normal human glomerular cells. N. Engl. J. Med. 320:741. (Letter.)
31. + T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc. Natl. Acad. Sci. USA 93:14076-14081.
32. Klotman, P. E., J. Rappaport, P. Ray, J. B. Kopp, R. Franks, L. A. Bruggeman, and A. L. Notkins. 1995. Transgenic models of HIV-1. AIDS 9:313-324.
33. Kopp, J. B., M. E. Klotman, S. H. Adler, L. A. Bruggeman, P. Dickie, N. J. Marinos, M. Eckhaus, J. L. Bryant, A. L. Notkins, and P. E. Klotman. 1992. Processive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc. Natl. Acad. Sci. USA 89:1577-1581.
34. Kourtis, A. P., C. Ibegbu, A. J. Nahmias, F. K. Lee, W. S. Clark, M. K. Sawyer, and S. Nesheim. 1996. Early progression of disease in HIV-infected infants with thymus dysfunction. N. Engl. J. Med. 335:1431-1436.
35. Leonard, J. M., J. W. Abramczuk, D. S. Pezen, R Rutledge, J. H. Belcher, F. S. Hakim, G. L. Lamperth, W. Travis, T. Fredrickson, et al. 1988. Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 242:1665-1670.
36. Lindemann, D., R. Wilhelm, P. Renard, A. Althage, R. Zinkernagel, and J. Mous. 1994. Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3′-long terminal repeat transgene. J. Exp. Med. 179:797-807.
37. Mazzucchelli, L., C. Hauser, K. Zgraggen, H. E. Wagner, M. W. Hess, J. A. Laissue, and C. Mueller. 1996. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J. Pathol. 178:201-206.
38. McLean, I. W., and P. K. Nakane. 1974. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J. Histochem. Cytochem. 22:1077-1083.
39. McSherry, G. D. 1996. Human immunodeficiency-virus-related pulmonary infections in children. Semin. Respir. Infect. 11:173-183.
40. Pantaleo, G., and A. S. Fauci. 1995. New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 13:487-512.
41. Rappaport, J., J. B. Kopp, and P. E. Klotman. 1994. Host virus interactions and the molecular regulation of HIV-1: role in the pathogenesis of HIV-associated nephropathy. Kidney Int. 46:16-27.
42. Rebai N., Z. Hanna, and P. Jolicoeur. Unpublished data.
43. Robertson E. J. 1987. Teratocarcinomas and embryonic stem cells: a practical approach. IRL Press Ltd., Oxford, United Kingdom.
44. Rothenberg, R., M. Woelfel, R. Stoneburner, J. Milberg, R. Parker, and B. Truman. 1987. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N. Engl. J. Med. 317:1297-1302.
45. Santoro, T. J., J. L. Bryant, J. Pellicoro, M. E. Klotman, J. B. Kopp, L. A. Bruggeman, R. R. Franks, A. L. Notkins, and P. E. Klotman. 1994. Growth failure and AIDS-like cachexia syndrome in HIV-1 transgenic mice. Virology 201:147-151.
46. Sasseville, V. G., M. M. Smith, C. R. Mackay, D. R. Pauley, K. G. Mansfield, D. J. Ringler, and A. A. Lackner. 1996. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am. J. Pathol. 149:1459-1467.
47. Schmidtmayerova, H., H. S. Nottet, G. Nuovo, T. Raabe, C. R. Flanagan, L. Dubrovsky, H. E. Gendelman, A. Cerami, M. Bukrinsky, and B. Sherry. 1996. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 93:700-704.
48. Schnittman, S. M., S. M. Denning, J. J. Greenhouse, J. S. Justement, M. K. Baseler, J. B. F. Haynes, and A. S. Fauci. 1990. Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. Proc. Natl. Acad. Sci. USA 87:7727-7731.
49. Schnittman, S. M., M. C. Psallidopoulos, H. C. Lane, L. Thompson, M. M. Baseler, F. C. H. Fox, N. P. Salzman, and A. S. Fauci. 1989. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305-308.
50. Scott, G. B., C. Hutto, R. W. Makuch, M. T. Mastrucci, T. O'Connor, C. D. Mitchell, E. J. Trapido, and W. P. Parks. 1989. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N. Engl. J. Med. 321:1791-1796.
51. Seemayer, T. A., A. C. Laroche, P. Russo, R. Malebranche, E. Arnoux, J. M. Guerin, G. Pierre, J. M. Dupuy, J. G. Gartner, W. S. Lapp, et al. 1984. Precocious thymic involution manifest by epithelial injury m the acquired immune deficiency syndrome. Hum. Pathol. 15:469-474.
52. Seney, F. D., Jr., D. K. Burns, and F. G. Silva. 1990. Acquired immunodeficiency syndrome and the kidney. Am. J. Kidney Dis. 16:1-13.
53. Skowronski, J., D. Parks, and R. Mariani. 1993. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:703-713.
54. Strauss, J., C. Abitbol, G. Zilleruelo, G. Scott, A. Paredes, S. M. Malaga, B. C. Mitchell, W. Parks, and V. Pardo. 1989. Renal disease in children with the acquired immunodeficiency syndrome. N. Engl. J. Med. 321:625-630.
55. Suttmann, U., J. Ockenga, O. Selberg, L. Hoogestraat, H. Deicher, and M. J. Muller, 1995. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:239-246.
56. Thomas, F. P., C. Chalk, R. Lalonde, Y. Robitaille, and P. Jolicoeur. 1994. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J. Virol. 68:7099-7107.
57. Tumminia, S. J., G. J. Jonak, R. J. Focht, Y. S. Cheng and P. Russell. 1996. Cataractogenesis in transgenic mice containing the HIV-1 protease linked to the lens alpha A-crystallin promoter. J. Biol. Chem. 271:425-431.
58. Vogel, J., S. H. Hinrichs, R. K. Reynolds, P. A. Luciw, and G. Jay. 1988. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335:606-611.
59. Zou, W., A. A. Lackner, M. Simon, I. Durand-Gasselin, P. Galanaud, R. C. Desrosiers, and D. Emilie. 1997. Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J. Virol. 71:1227-1236.